These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10544095)

  • 1. Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters.
    Kamrud KI; Hooper JW; Elgh F; Schmaljohn CS
    Virology; 1999 Oct; 263(1):209-19. PubMed ID: 10544095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection.
    Hooper JW; Kamrud KI; Elgh F; Custer D; Schmaljohn CS
    Virology; 1999 Mar; 255(2):269-78. PubMed ID: 10069952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus.
    Safronetz D; Hegde NR; Ebihara H; Denton M; Kobinger GP; St Jeor S; Feldmann H; Johnson DC
    J Virol; 2009 Jul; 83(14):7285-95. PubMed ID: 19403663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines against hantaviruses.
    Hooper JW; Li D
    Curr Top Microbiol Immunol; 2001; 256():171-91. PubMed ID: 11217404
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.
    Hooper JW; Custer DM; Thompson E; Schmaljohn CS
    J Virol; 2001 Sep; 75(18):8469-77. PubMed ID: 11507192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactive immune responses in mice after genetic vaccination with cDNA encoding hantavirus nucleocapsid proteins.
    Lindkvist M; Lahti K; Lilliehöök B; Holmström A; Ahlm C; Bucht G
    Vaccine; 2007 Feb; 25(9):1690-9. PubMed ID: 17110000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine.
    Brocato RL; Josleyn MJ; Wahl-Jensen V; Schmaljohn CS; Hooper JW
    Clin Vaccine Immunol; 2013 Feb; 20(2):218-26. PubMed ID: 23239797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice.
    Lee BH; Yoshimatsu K; Araki K; Okumura M; Nakamura I; Arikawa J
    Vaccine; 2006 Apr; 24(15):2928-34. PubMed ID: 16426712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.
    Brown KS; Safronetz D; Marzi A; Ebihara H; Feldmann H
    J Virol; 2011 Dec; 85(23):12781-91. PubMed ID: 21917979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncated hantavirus nucleocapsid proteins for serotyping Hantaan, Seoul, and Dobrava hantavirus infections.
    Araki K; Yoshimatsu K; Ogino M; Ebihara H; Lundkvist A ; Kariwa H; Takashima I; Arikawa J
    J Clin Microbiol; 2001 Jul; 39(7):2397-404. PubMed ID: 11427545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus.
    Hooper JW; Ferro AM; Wahl-Jensen V
    J Virol; 2008 Feb; 82(3):1332-8. PubMed ID: 18032485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine.
    Custer DM; Thompson E; Schmaljohn CS; Ksiazek TG; Hooper JW
    J Virol; 2003 Sep; 77(18):9894-905. PubMed ID: 12941899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates.
    Hooper JW; Custer DM; Smith J; Wahl-Jensen V
    Virology; 2006 Mar; 347(1):208-16. PubMed ID: 16378630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term single-dose efficacy of a vesicular stomatitis virus-based Andes virus vaccine in Syrian hamsters.
    Prescott J; DeBuysscher BL; Brown KS; Feldmann H
    Viruses; 2014 Jan; 6(2):516-23. PubMed ID: 24492621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small animal jet injection technique results in enhanced immunogenicity of hantavirus DNA vaccines.
    Brocato RL; Kwilas SA; Josleyn MD; Long S; Zeng X; Perley CC; Principe LM; Somerville B; Cohen MV; Hooper JW
    Vaccine; 2021 Feb; 39(7):1101-1110. PubMed ID: 33483212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hantavirus Gc induces long-term immune protection via LAMP-targeting DNA vaccine strategy.
    Jiang DB; Zhang JP; Cheng LF; Zhang GW; Li Y; Li ZC; Lu ZH; Zhang ZX; Lu YC; Zheng LH; Zhang FL; Yang K
    Antiviral Res; 2018 Feb; 150():174-182. PubMed ID: 29273568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA vaccination of mice with a plasmid encoding Puumala hantavirus nucleocapsid protein mimics the B-cell response induced by virus infection.
    Koletzki D; Schirmbeck R; Lundkvist A; Meisel H; Krüger DH; Ulrich R
    J Biotechnol; 2001 Nov; 84(1):73-8. PubMed ID: 11035190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel minigenome and recombinant VSV expressing Seoul hantavirus glycoprotein-based assays to identify anti-hantavirus therapeutics.
    Shrivastava-Ranjan P; Jain S; Chatterjee P; Montgomery JM; Flint M; Albariño C; Spiropoulou CF
    Antiviral Res; 2023 Jun; 214():105619. PubMed ID: 37142192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines against hantaviruses.
    Hjelle B
    Expert Rev Vaccines; 2002 Oct; 1(3):373-84. PubMed ID: 12901576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.